Divisadero Street Capital Management, LP → Beta Bionics, Inc. BBNX

Stake: — Shares: — Class: Common Stock, $0.0001 par value per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

6 filings by this filer

5 other filings in the data moat

Short Interest · settle 2026-07-15

DTC 6.97

6,609,679 shares short · -3.1% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $30.08M

Point72 Asset Mgmt

Other Filings by Divisadero Street Capital Management, LP

Filed	Form	Issuer	Stake	Shares
2026-07-06	SCHEDULE 13G	Ethos Technologies Inc. LIFE	—	—	view →
2026-06-30	SCHEDULE 13G	TheRealReal, Inc. REAL	—	—	view →
2026-06-16	SCHEDULE 13G	Flywire Corp FLYW	—	—	view →
2026-05-19	SCHEDULE 13G	Willdan Group, Inc. WLDN	—	—	view →
2024-01-03	SC	Groupon, Inc. GRPN	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →